Revenue Recognition (Tables)

6 Months Ended

Dec. 31, 2018

Revenue Recognition [Abstract]

Schedule of revenues disaggregated by business segment and product lines

	Six months ended December 31, 2018
			Pharmaceutical		Performance		Consolidated
	Human Health		Ingredients		Chemicals		Totals
Finished dosage from generic drugs	$	142,876	$	-	$	-	$	142,876
Nutraceutical products		22,951		-		-		22,951
Pharmaceutical intermediates		-		22,754		-		22,754
Active pharmaceutical ingredients (APIs)		-		58,136		-		58,136
Specialty chemicals		-		-		67,803		67,803
Agricultural protection products		-		-		13,534		13,534
	$	165,827	$	80,890	$	81,337	$	328,054

	Six months ended December 31, 2017
			Pharmaceutical		Performance		Consolidated
	Human Health		Ingredients		Chemicals		Totals
Finished dosage from generic drugs	$	186,322	$	-	$	-	$	186,322
Nutraceutical products		23,159		-		-		23,159
Pharmaceutical intermediates		-		19,975		-		19,975
Active pharmaceutical ingredients (APIs)		-		50,230		-		50,230
Specialty chemicals		-		-		64,553		64,553
Agricultural protection products		-		-		12,245		12,245
	$	209,481	$	70,205	$	76,798	$	356,484

	Three months ended December 31, 2018
			Pharmaceutical		Performance		Consolidated
	Human Health		Ingredients		Chemicals		Totals
Finished dosage from generic drugs	$	73,663	$	-	$	-	$	73,663
Nutraceutical products		11,318		-		-		11,318
Pharmaceutical intermediates		-		12,532		-		12,532
Active pharmaceutical ingredients (APIs)		-		29,510		-		29,510
Specialty chemicals		-		-		31,582		31,582
Agricultural protection products		-		-		5,044		5,044
	$	84,981	$	42,042	$	36,626	$	163,649

	Three months ended December 31, 2017
			Pharmaceutical		Performance		Consolidated
	Human Health		Ingredients		Chemicals		Totals
Finished dosage from generic drugs	$	90,761	$	-	$	-	$	90,761
Nutraceutical products		12,705		-		-		12,705
Pharmaceutical intermediates		-		9,839		-		9,839
Active pharmaceutical ingredients (APIs)		-		23,790		-		23,790
Specialty chemicals		-		-		30,533		30,533
Agricultural protection products		-		-		3,601		3,601
	$	103,466	$	33,629	$	34,134	$	171,229

Schedule of activity in the consolidated balance sheet for contra assets and liability for price concessions

	Accruals for Chargebacks, Rebates, Returns and Other Allowances
							Government			Non-Governmental			Sales
	Chargebacks			Returns			Reimbursed Rebates			Rebates & Other			Discounts
Balance at June 30, 2018	$	66,687		$	41,511		$	9,658		$	86,259		$	6,408
Current period provision		344,813			8,949			7,562			83,023			14,541
Credits issued during the period		(346,117	)		(4,824	)		(4,227	)		(85,254	)		(14,857	)
Balance at December 31, 2018	$	65,383		$	45,636		$	12,993		$	84,028		$	6,092